For example, in human lung cancer cell lines, SMARCA4-inactivating mutations are frequently found38, and inactivating mutations in SMARCA4 increase the sensitivity to Aurora kinase inhibitors in small cell lung cancer39, suggesting that SMARCA4 acts as a tumor suppressor in this context. Here, SMARCA4 is linked to neoplasm.